Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

in the last decade, lots of attemps have been done to identify new technologies able to reply the efficacy of gold standard technique for treating BPH, but with a better safety profile. The introduction of laser techniques allowed to reduce complication rates. Among these, considerable importance had Holep and PVP. Aquablation is a recent technique for LUTS treatment. It is minimally invasive, robot-assisted and ultrasound-guided to ablate the prostate in targeted way and in "heat-free" way. It works with high pression water jet. However, in literature informations about disobstructive capacity of minimally invasive techniques, evaluated with invasive urodynamic tests, are low.

The enrolled subjects will undergo surgical treatment with one of the techniques under study: Aquablation, HoLEP or PVP.

Outpatient visits will be performed at 1, 3 and 6 months after the surgical treatment. During the sixth month visit an invasive urodynamic examination will be performed

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

NCT04781049

Prostate Hyperplasia Benign Prostatic Hyperplasia Benign Prostatic Hypertrophy +1 more

COMPLETED NA

Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy

NCT02243540

Prostatic Hyperplasia

UNKNOWN

WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia

NCT04801381

BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

ACTIVE_NOT_RECRUITING NA

Waterjet Prostate Ablation

NCT03938194

Benign Prostatic Hyperplasia

TERMINATED NA

Urodynamic Feasibility Study Utilizing the UroLift® System

NCT04271020

Benign Prostatic Hyperplasia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

in the last decade, lots of attemps have been done to identify new technologies able to reply the efficacy of gold standard technique for treating BPH, but with a better safety profile. The introduction of laser techniques allowed to reduce complication rates. Among these, considerable importance had Holep and PVP. Aquablation is a recent technique for LUTS treatment. It is minimally invasive, robot-assisted and ultrasound-guided to ablate the prostate in targeted way and in "heat-free" way. It works with high pression water jet.

However, in literature informations about disobstructive capacity of minimally invasive techniques, evaluated with invasive urodynamic tests, are low.

In particular, about Aquablation, just in one trial is reported the reduction of BOOI, from 49 to 24 in 6 months after surgery, but this information is not associated with standard deviation and statistical significance.

Perreira-Carreia, J.A. et al, in 2012 reported a medium BOOI variation after 6 months by surgery, from 60 to 8,7 (p\<0,001) even if procedure was conducted with laser 120 W.

In 2014 Know, O. and coll., reported BOOI reduction after Holep from 54,9 ± 30,2 to 3,4 ± 17,4 (p\<0,001).

Actually, there are not trials comparing Aquablation with others mininvasive techniques to treat LUTS by BHP (in particular Holep and PVP).

This comparison is very interesting because of the specific benefits of each technique.

General and specific aims:

1. non inferiority evaluation of the BOOI variations in patients with LUTS caused by cervico-urethral obstruction by BHP undergone to endoscopic surgery with aquablation versus patients operated with laser endoscopic surgery (primary goal);
2. Evaluation of the IPSS score variations in two groups of patients,
3. Evaluation of Qmax variations with uroflowmetry and post-voiding residue in two groups;
4. Evaluation of sexual satisfaction by IIEF-5 survey and evaluation of presence of anejaculation in two groups;
5. Evaluation of total-PSA variation in two groups;
6. Evaluation of operative times, hospitalization and variations of haemoglobin and haematocrit value in two groups;
7. Evaluation of appearing of side effects (grade 1 and ≥ 2 by Clavien-Dindo) occurred in perioperative period and at 1, 3 and 6 months after surgery;

Inclusion criteria:

* age ≥ 40 years and \<90 years;
* moderate-to-severe lower urinary tract symptoms (IPSS ≥ 12)
* poor efficacy or tolerance to medical therapy for BPH
* transrectal ultrasound prostate volume between 30 and 120 ml
* ability to express written informed consent.

Exclusion criteria:

* previous surgical treatments for BPH
* indwelling bladder catheter or clean intermittent catheterization
* bladder stones
* severe detrusor hypocontractility (BCI \<50) or detrusorial acontractility
* urethral strictures
* neurological bladder
* not replaceable anticoagulant or antiplatelet drugs for severe cardiological comorbidity
* bladder cancer;
* diagnosis or clinical suspicion of prostatic cancer;

Treatment The enrolled subjects will undergo surgical treatment with one of the techniques under study: Aquablation, HoLEP or PVP.

The study population will be divided into two cohorts based on prostate volume measured by transrectal ultrasound. Thereafter, patients with a prostate volume between 30 and 65 ml will be assigned to the aquablation arm or PVP arm, while patients with a prostate volume over 65 ml will be subjected to aquablation or HoLEP. The assignment to each of the arms will be randomized, using an on-line software for block randomization.

Follow-up:

Follow-up visits will be conducted by a blinded research team. Outpatient visits will be performed at 1, 3 and 6 months after the surgical treatment. During the sixth month visit an invasive urodynamic examination will be performed with cystomanometry and pressure-flow study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Prostatic Hyperplasia (BPH)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

non inferiority, blinded, prospective, randomized clinical trial.

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

double blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aquablation

patients with prostatic volume included between 30 and 120 ml will be treated with water jet (aquablation). patients with prostatic volume \> 65 ml will be compared with holep arm and patients with prostatic volume included between 30 and 65 ml will be compared with pvp arm.

Group Type EXPERIMENTAL

aquablation

Intervention Type DEVICE

minimally invasive, robot-assisted and ultrasound-guided ablation of the prostate in targeted way and in "heat-free" way working by high pression water jet

holep

patients with prostatic volume \> 65 ml will be treated with holmium laser technique (Holep)

Group Type ACTIVE_COMPARATOR

holep

Intervention Type DEVICE

holmium laser enucleation of prostate

pvp

patients with prostatic volume included between 30 and 65 ml will be treated with photoselective vaporization of prostate (pvp).

Group Type ACTIVE_COMPARATOR

pvp

Intervention Type DEVICE

photoselectivevaporization of prostate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

aquablation

minimally invasive, robot-assisted and ultrasound-guided ablation of the prostate in targeted way and in "heat-free" way working by high pression water jet

Intervention Type DEVICE

holep

holmium laser enucleation of prostate

Intervention Type DEVICE

pvp

photoselectivevaporization of prostate

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* moderate-to-severe lower urinary tract symptoms (IPSS ≥ 12)
* poor efficacy or tolerance to medical therapy for BPH
* transrectal ultrasound prostate volume between 30 and 120 ml
* ability to express written informed consent.

Exclusion Criteria

* previous surgical treatments for BPH
* indwelling bladder catheter or clean intermittent catheterization
* bladder stones
* severe detrusor hypocontractility (BCI \<50) or detrusorial acontractility
* urethral strictures
* neurological bladder
* not replaceable anticoagulant or antiplatelet drugs for severe cardiological comorbidity
* bladder cancer;
* diagnosis or clinical suspicion of prostatic cancer

Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No